Caffeine reduces mistakes made by shift workers

May 11, 2010

Caffeine can help those working shifts or nights to make fewer errors, according to a new study by Cochrane researchers. The findings have implications for health workers and for any industry relying on shift or night work, such as transportation.

More than 15% of workers in industrialised countries are involved in some shift or night time work, which may upset natural circadian rhythms or 'body clocks'. In so-called disorder (SWD), workers sleep only for short periods and consequently can become very sleepy during working hours. Sleepiness is thought to increase the risk of adverse events such as traffic crashes, occupational injuries and .

The researchers reviewed data from 13 trials studying the effects of caffeine on performance in shift workers, mostly in simulated working conditions. Caffeine was given in coffee, pills, or caffeinated food. In some trials, performance was assessed by tasks such as driving, whereas in others it was assessed by neuropsychological tests. Caffeine appeared to reduce errors compared to placebos or naps, and improve performance in various neuropsychological tests, including those focusing on memory, attention, perception and concept formation and reasoning.

None of the trials measured injuries directly, but improved performance may translate into reduced numbers of injuries caused by sleepiness, according to researchers. "It seems reasonable to assume that reduced errors are associated with fewer injuries, although we cannot quantify such a reduction," says lead researcher Katharine Ker of the London School of Tropical Medicine in London, UK.

The average age in most trials was between 20 and 30 years and thus, because the effect of disruption to the circadian rhythm varies with age, there is still a need for more research on how caffeine affects alertness in older workers. The study also finds that there is a need for research to explore the effects of compared to other measures in order to reduce errors made by .

Related Stories

Recommended for you

Drug found that induces apoptosis in myofibroblasts reducing fibrosis in scleroderma

December 15, 2017
(Medical Xpress)—An international team of researchers has found that the drug navitoclax can induce apoptosis (self-destruction) in myofibroblasts in mice, reducing the spread of fibrosis in scleroderma. In their paper ...

How defeating THOR could bring a hammer down on cancer

December 14, 2017
It turns out Thor, the Norse god of thunder and the Marvel superhero, has special powers when it comes to cancer too.

Researchers track muscle stem cell dynamics in response to injury and aging

December 14, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) describes the biology behind why muscle stem cells respond differently to aging or injury. The findings, published in Cell Stem Cell, ...

'Human chronobiome' study informs timing of drug delivery, precision medicine approaches

December 13, 2017
Symptoms and efficacy of medications—and indeed, many aspects of the human body itself—vary by time of day. Physicians tell patients to take their statins at bedtime because the related liver enzymes are more active during ...

Study confirms link between the number of older brothers and increased odds of being homosexual

December 12, 2017
Groundbreaking research led by a team from Brock University has further confirmed that sexual orientation for men is likely determined in the womb.

Potassium is critical to circadian rhythms in human red blood cells

December 12, 2017
An innovative new study from the University of Surrey and Cambridge's MRC Laboratory of Molecular Biology, published in the prestigious journal Nature Communications, has uncovered the secrets of the circadian rhythms in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.